Computed Tomography Market - Global Forecast 2026-2032

The Computed Tomography Market is projected to reach USD 8.32 Billion in 2026. It is expected to continue growing at a CAGR of 6.45%, reaching USD 12.17 Billion by 2032.

Computed tomography (CT) remains one of the most strategically important medical imaging modalities because it delivers rapid, high-resolution cross-sectional visualization for emergency medicine, oncology, cardiology, neurology, pulmonology, and image-guided interventions. Hospitals and imaging centers rely on CT scanners for time-sensitive diagnosis in trauma, stroke, pulmonary embolism, coronary artery disease, cancer staging, and post-treatment surveillance.

The computed tomography landscape is being shaped by the clinical need for faster throughput, lower radiation dose, improved image quality, and consistent diagnostic confidence. Demand is reinforced by aging populations, the rising global burden of noncommunicable diseases, and the continued expansion of advanced diagnostic imaging infrastructure across mature and emerging healthcare systems.

Innovation is increasingly centered on low-dose CT, spectral CT, dual-energy CT, wide-detector systems, portable CT, and photon-counting CT, alongside artificial intelligence-enabled reconstruction and workflow automation. For industry leaders, CT is no longer only a hardware category; it is an integrated ecosystem spanning scanners, detectors, software, service contracts, cloud connectivity, cybersecurity, and clinical decision support.

Transformative Shifts in the CT Landscape

The CT landscape is undergoing a structural shift from equipment replacement cycles toward digitally connected, protocol-driven imaging platforms. Healthcare providers are prioritizing systems that reduce scan time, standardize image acquisition, support enterprise imaging integration, and improve operational productivity across radiology departments.

A major transformation is the movement toward patient-centered and value-based imaging. Providers are under pressure to improve diagnostic yield while managing radiation exposure, staffing shortages, reimbursement scrutiny, and rising procedure volumes. This is accelerating adoption of dose-optimization tools, automated positioning, iterative and deep learning reconstruction, and standardized reporting workflows.

Another important shift is the diversification of CT use sites. While tertiary hospitals remain central to advanced applications such as cardiac CT, oncology staging, and stroke imaging, outpatient imaging networks and ambulatory care centers are expanding access to routine CT examinations. At the same time, sustainability, energy efficiency, uptime guarantees, lifecycle service models, and secure connectivity are becoming decisive procurement factors.

Cumulative Impact of Artificial Intelligence on CT

Artificial intelligence is creating cumulative value across the CT imaging chain, from patient positioning and protocol selection to image reconstruction, triage, segmentation, quantification, and structured reporting. AI-enabled reconstruction can support lower-dose scanning while preserving image quality, and AI triage tools can help flag urgent findings such as intracranial hemorrhage, pulmonary embolism, pneumothorax, and large vessel occlusion.

Regulatory momentum supports the long-term role of AI in CT. The U.S. FDA has authorized hundreds of AI-enabled medical devices across imaging and radiology, demonstrating that software is becoming a core differentiator for diagnostic platforms. However, real-world adoption depends on validated performance, clinical workflow fit, interoperability with PACS, RIS, and electronic health records, transparent governance, and continuous monitoring for bias and model drift.

The cumulative impact of AI is strongest where it improves measurable outcomes: reduced turnaround time, fewer repeat scans, improved radiologist productivity, lower radiation exposure, and more consistent quantitative assessment in oncology, cardiology, and lung disease. Vendors that combine CT hardware innovation with secure, explainable, and clinically validated AI are better positioned in competitive procurement cycles.

Key Regional Insights for Computed Tomography

Asia-Pacific is one of the most dynamic CT regions, supported by large patient populations, expanding hospital networks, and growing investment in diagnostic infrastructure. China, India, Japan, South Korea, and Australia are central to regional demand, with Japan and South Korea demonstrating advanced adoption of high-end CT systems and China and India showing strong volume-led demand across public and private care settings.

North America remains a technology-leading region, driven by high imaging utilization, a broad installed base, advanced clinical protocols, and early adoption of AI-enabled imaging. The United States anchors regional demand through extensive hospital networks, outpatient imaging centers, and regulatory pathways that support advanced CT and imaging software commercialization, while Canada emphasizes access, quality, public procurement, and modernization of diagnostic capacity.

Latin America shows growing CT demand as Brazil and Mexico expand diagnostic capacity and private healthcare investment. The region faces budget constraints and uneven access, but demand is supported by urban hospital modernization, oncology care expansion, and the need for emergency imaging. Europe remains a mature and regulation-driven region, with Germany, France, Italy, Spain, and the United Kingdom emphasizing quality standards, dose management, sustainability, interoperability, and compliance with medical device regulations.

The Middle East is investing in advanced imaging as part of healthcare modernization strategies, especially across Gulf countries where specialty hospitals, trauma care, oncology programs, and medical tourism initiatives support premium CT adoption. Africa remains underpenetrated compared with other regions, but long-term opportunities are tied to public health investment, donor-supported infrastructure, urban hospital development, workforce training, and scalable service models that address maintenance and affordability.

Key Group Insights Across Major Economic Blocs

ASEAN demand is supported by hospital expansion, medical tourism, and rising chronic disease diagnosis across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The group presents a dual-market structure, with advanced urban hospitals adopting premium CT systems while broader healthcare networks require cost-effective, reliable platforms with strong service support and technologist training.

The GCC is a high-investment healthcare group where Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman are expanding specialty care, trauma services, oncology programs, and digital health infrastructure. CT procurement in the GCC is closely linked to national healthcare transformation plans, private hospital growth, medical tourism, and demand for premium imaging technologies that support rapid diagnosis and integrated care pathways.

The European Union is shaped by harmonized regulatory expectations, radiation safety principles, public procurement discipline, and strong emphasis on interoperability, cybersecurity, and sustainability. EU healthcare systems continue to invest in CT modernization, but purchasing decisions are influenced by lifecycle cost, dose optimization, compliance with evolving medical device and data protection frameworks, and the need to improve diagnostic access.

BRICS countries represent scale-driven CT opportunities, led by China and India and supported by Brazil, Russia, and South Africa. These markets combine large disease burdens with uneven imaging access, creating demand for both high-end tertiary systems and value-oriented scanners. G7 countries remain critical for innovation, clinical validation, and premium adoption because they combine advanced healthcare infrastructure with strong research institutions. NATO countries, particularly in North America and Europe, also prioritize resilient healthcare infrastructure, emergency readiness, secure medical technology supply chains, and interoperable digital systems.

Key Country Insights in Computed Tomography

The United States remains a leading country for advanced CT adoption, supported by high imaging utilization, outpatient imaging networks, emergency medicine demand, and rapid commercialization of AI-enabled radiology tools. Canada’s CT environment is shaped by public healthcare priorities, wait-time management, quality standards, and investments in modern imaging capacity, while Mexico benefits from private hospital expansion, urban diagnostic growth, and cross-border healthcare demand.

Brazil leads Latin American CT activity through its large hospital base, oncology needs, and private healthcare sector, while the United Kingdom emphasizes imaging access, National Health Service capacity planning, and diagnostic center expansion. Germany remains a European imaging powerhouse with strong hospital infrastructure and demand for premium CT systems. France prioritizes quality, radiation protection, and national imaging modernization, while Italy and Spain continue to invest in equipment renewal, oncology imaging, emergency care, and regional healthcare upgrades.

Russia maintains demand for CT across large public healthcare networks and regional hospital systems, although procurement dynamics are influenced by economic and supply-chain conditions. China is a scale leader, combining domestic manufacturing capacity, public hospital investment, and rapid adoption of advanced imaging in major cities. India shows strong potential due to expanding private diagnostics, medical tourism, and rising chronic disease detection, although affordability, access, and workforce availability remain important constraints.

Japan is a mature, high-utilization CT environment with strong adoption of advanced scanner configurations and an aging population that supports sustained diagnostic demand. Australia emphasizes quality, access, and advanced imaging across public and private systems, while South Korea stands out for technologically advanced hospitals, strong digital health adoption, and a competitive private medical sector.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize CT platforms that combine image quality, dose efficiency, and workflow automation with measurable economic value. Procurement decisions increasingly depend on total cost of ownership, uptime, service responsiveness, cybersecurity, energy efficiency, and compatibility with enterprise imaging ecosystems.

Vendors should invest in clinically validated AI that solves operational pain points rather than adding disconnected features. High-impact areas include automated protocoling, low-dose reconstruction, urgent finding triage, lesion measurement, cardiac analysis, lung nodule assessment, and structured reporting. Clear evidence on productivity gains, diagnostic accuracy, and patient safety is essential for adoption.

Healthcare providers should standardize CT protocols, monitor radiation dose, train technologists on advanced capabilities, and integrate CT data into multidisciplinary care pathways. Market participants should develop differentiated strategies for mature and emerging regions, balancing premium innovation with affordable systems, financing models, remote service, preventive maintenance, and local training.

Research Methodology

This executive summary is developed using a structured research methodology that combines secondary research, data triangulation, and expert interpretation. Inputs include publicly available information from health authorities, regulatory agencies, peer-reviewed literature, hospital procurement trends, clinical guideline bodies, and international organizations such as WHO, OECD, FDA, European Commission sources, and national health agencies.

The analysis evaluates CT demand drivers, technology trends, regional adoption patterns, regulatory influences, and competitive positioning without relying on market sizing, share estimates, or forecasts. Findings are validated through cross-comparison of multiple credible sources to avoid reliance on isolated claims. Emphasis is placed on verifiable signals such as disease burden, imaging utilization, healthcare infrastructure investment, AI device authorization trends, installed-base modernization, and replacement demand.

The methodology is designed to support executive decision-making by connecting clinical need, technology innovation, reimbursement pressure, regulatory requirements, and regional readiness. Qualitative insights are interpreted through the lens of practical commercial relevance for manufacturers, software developers, healthcare providers, investors, and channel partners.

Conclusion

Computed tomography is entering a new phase defined by intelligent imaging, dose-conscious care, faster workflows, and integrated diagnostic ecosystems. Demand is supported by the global burden of cancer, cardiovascular disease, neurological emergencies, trauma, and chronic respiratory conditions, all of which require timely and accurate imaging.

The most competitive CT strategies align hardware innovation with AI, service reliability, interoperability, cybersecurity, and region-specific affordability. Mature regions reward premium performance, automation, and enterprise integration, while emerging regions require scalable, durable, and cost-effective CT solutions supported by training and reliable service infrastructure.

As healthcare systems pursue earlier diagnosis and more efficient care delivery, CT remains central to modern medical imaging. Organizations that demonstrate clinical value, operational efficiency, radiation safety, and trusted technology governance are best positioned to build resilient long-term advantage.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Computed Tomography Market, by Product Type

7.1. Introduction
7.2. Multi Slice
7.2.1. 16 Slices
7.2.2. 64 Slices
7.2.3. Above 64 Slices
7.3. Single Slice

8. Computed Tomography Market, by Component

8.1. Introduction
8.2. Hardware
8.3. Services
8.4. Software

9. Computed Tomography Market, by Application

9.1. Introduction
9.2. Cardiology
9.2.1. Calcium Scoring
9.2.2. Cardiac Structure Assessment
9.2.3. Coronary CT Angiography (CTA)
9.3. Gastroenterology
9.4. Neurology
9.4.1. Brain perfusion Studies
9.4.2. Brain Tumor Assessment
9.4.3. Skull Fractures
9.4.4. Stroke Evaluation
9.5. Oncology
9.5.1. Biopsy Guidance
9.5.2. Staging
9.5.3. Treatment Monitoring
9.5.4. Tumor Detection
9.6. Orthopedics
9.7. Trauma

10. Computed Tomography Market, by End User

10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Clinics
10.4. Diagnostic Imaging Centers
10.5. Hospitals

11. Computed Tomography Market, by Modality

11.1. Introduction
11.2. Stationary
11.3. Portable

12. Computed Tomography Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Computed Tomography Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Computed Tomography Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Allengers Medical Systems Ltd.
16.2. Arineta Ltd.
16.3. Basda Medical Apparatus Co., Ltd.
16.4. Bruker Corporation
16.5. Canon Medical Systems Corporation
16.6. Carestream Health, Inc.
16.7. Fujifilm Holdings Corporation
16.8. GE HealthCare Technologies Inc.
16.9. Hologic, Inc.
16.10. Izotropic Corporation
16.11. J. Morita Corporation
16.12. Koning Corporation
16.13. Koninklijke Philips N.V.
16.14. MARS Bioimaging Ltd.
16.15. MinFound Medical Systems Co., Ltd.
16.16. MR Solutions Ltd.
16.17. NeuroLogica Corp.
16.18. Neusoft Medical Systems Co., Ltd.
16.19. Planmeca Oy
16.20. Shenzhen Anke High-tech Co., Ltd.
16.21. Shimadzu Corporation
16.22. Siemens Healthineers AG
16.23. Trivitron Healthcare
16.24. United Imaging Healthcare Co., Ltd.
16.25. Vatech Co., Ltd.
16.26. Xoran Technologies, Inc.

List of Figures

FIGURE 1. GLOBAL COMPUTED TOMOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL COMPUTED TOMOGRAPHY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL COMPUTED TOMOGRAPHY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL COMPUTED TOMOGRAPHY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL COMPUTED TOMOGRAPHY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL MULTI SLICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL MULTI SLICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL MULTI SLICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL 16 SLICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL 16 SLICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL 16 SLICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL 64 SLICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL 64 SLICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL 64 SLICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ABOVE 64 SLICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ABOVE 64 SLICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ABOVE 64 SLICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SINGLE SLICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SINGLE SLICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SINGLE SLICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CALCIUM SCORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CALCIUM SCORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CALCIUM SCORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CARDIAC STRUCTURE ASSESSMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CARDIAC STRUCTURE ASSESSMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CARDIAC STRUCTURE ASSESSMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CORONARY CT ANGIOGRAPHY (CTA) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CORONARY CT ANGIOGRAPHY (CTA) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CORONARY CT ANGIOGRAPHY (CTA) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL BRAIN PERFUSION STUDIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BRAIN PERFUSION STUDIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BRAIN PERFUSION STUDIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN TUMOR ASSESSMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN TUMOR ASSESSMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN TUMOR ASSESSMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SKULL FRACTURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SKULL FRACTURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SKULL FRACTURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL STROKE EVALUATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL STROKE EVALUATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL STROKE EVALUATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL BIOPSY GUIDANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL BIOPSY GUIDANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL BIOPSY GUIDANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL STAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL STAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL TREATMENT MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL TREATMENT MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL TREATMENT MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL TUMOR DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL TUMOR DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TUMOR DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ORTHOPEDICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ORTHOPEDICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ORTHOPEDICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 132. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 135. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 136. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 137. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 138. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 139. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 140. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. EUROPE COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 152. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 154. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 155. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 156. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 158. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 159. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 160. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. AFRICA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 165. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 166. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 167. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 169. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 170. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 171. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. ASEAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 173. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 175. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 176. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 177. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 179. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 180. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 181. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. GCC COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 193. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 196. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 197. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 199. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 200. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 201. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. BRICS COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 203. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 206. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 207. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 209. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 210. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 211. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. G7 COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 213. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 215. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 216. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 217. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 219. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 220. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 221. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. NATO COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 234. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 236. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 237. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 238. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 240. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 241. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 242. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. CANADA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 244. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 245. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 246. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 247. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 248. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 249. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 250. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 251. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 252. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. MEXICO COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 254. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 274. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 276. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 277. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 278. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 280. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 281. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 282. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. GERMANY COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 284. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 287. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 288. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 290. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 291. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 292. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. FRANCE COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 294. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 304. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 307. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 308. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 310. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 311. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 312. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 313. ITALY COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 314. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 317. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 318. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 320. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 321. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 322. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 323. SPAIN COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 324. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 327. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 328. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 329. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 330. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 331. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 332. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 333. CHINA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 334. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 335. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 336. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 337. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 338. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 339. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 340. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 341. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 342. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 343. INDIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 344. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 346. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 347. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 348. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 349. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 350. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 351. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 352. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 353. JAPAN COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 354. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 355. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 356. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 357. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 358. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 359. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 360. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 361. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 362. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. AUSTRALIA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 364. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 365. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 366. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI SLICE, 2017-2032 (USD MILLION)
TABLE 367. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 368. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 369. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 370. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 371. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 372. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 373. SOUTH KOREA COMPUTED TOMOGRAPHY MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 374. GLOBAL COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 375. GLOBAL COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

Allengers Medical Systems Ltd.
Arineta Ltd.
Basda Medical Apparatus Co., Ltd.
Bruker Corporation
Canon Medical Systems Corporation
Carestream Health, Inc.
Fujifilm Holdings Corporation
GE HealthCare Technologies Inc.
Hologic, Inc.
Izotropic Corporation
J. Morita Corporation
Koning Corporation
Koninklijke Philips N.V.
MARS Bioimaging Ltd.
MinFound Medical Systems Co., Ltd.
MR Solutions Ltd.
NeuroLogica Corp.
Neusoft Medical Systems Co., Ltd.
Planmeca Oy
Shenzhen Anke High-tech Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Trivitron Healthcare
United Imaging Healthcare Co., Ltd.
Vatech Co., Ltd.
Xoran Technologies, Inc.

Table Information

Report Attribute	Details
No. of Pages	190
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 8.32 Billion
Forecasted Market Value ( USD ) by 2032	$ 12.17 Billion
Compound Annual Growth Rate	6.4%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the CT Landscape

Cumulative Impact of Artificial Intelligence on CT

Key Regional Insights for Computed Tomography

Key Group Insights Across Major Economic Blocs

Key Country Insights in Computed Tomography

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Spine X-Ray & Computed Tomography Market - Global Forecast 2026-2032

Medical Photon-counting Computed Tomography Equipment Market - Global Forecast 2026-2032

Dual and Multi Energy Computed Tomography - Global Strategic Business Report

Computed Tomography Market - A Global and Regional Analysis: Type, Technology, End User, and Regional Analysis, 2026-2036

Computed Tomography (CT) Scanners - Global Strategic Business Report